These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Salivary miR-93 and miR-200a as post-radiotherapy biomarkers in head and neck squamous cell carcinoma. Greither T; Vorwerk F; Kappler M; Bache M; Taubert H; Kuhnt T; Hey J; Eckert AW Oncol Rep; 2017 Aug; 38(2):1268-1275. PubMed ID: 28677748 [TBL] [Abstract][Full Text] [Related]
13. A Novel Saliva and Serum miRNA Panel as a Potential Useful Index for Oral Cancer and the Association of miR-21 with Smoking History: a Pilot Study. Vageli DP; Doukas PG; Shah R; Boyi T; Liu C; Judson BL Cancer Prev Res (Phila); 2023 Dec; 16(12):653-659. PubMed ID: 37683274 [TBL] [Abstract][Full Text] [Related]
14. Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients. Yan Y; Wang X; Venø MT; Bakholdt V; Sørensen JA; Krogdahl A; Sun Z; Gao S; Kjems J Oncotarget; 2017 Jan; 8(5):8206-8214. PubMed ID: 28030794 [TBL] [Abstract][Full Text] [Related]
15. miR-196b-5p and miR-107 Expression Differentiates Ocular Sebaceous Carcinoma from Squamous Cell Carcinoma of the Conjunctiva. de Keizer ROB; Vriends ALM; Hötte GJ; Paridaens DA; Wiemer EAC; Verdijk RM Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563269 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis. Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116 [TBL] [Abstract][Full Text] [Related]